Back to Journals » ImmunoTargets and Therapy

ImmunoTargets and Therapy

COPE logo
ISSN: 2253-1556

Journal Image

Editor-in-Chief: Professor Michael R Shurin

ImmunoTargets and Therapy is an international journal that aims to present and publish basic and clinical research on the aspects of immunology in health and disease. ImmunoTargets and Therapy is primarily focused on the immunological basis of disease and explores the evidence behind new and existing immunotherapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). 


This journal offers Accelerated Publication.

 

Latest articles:

- 5 records -

Role of Cytokines in Bone Diseases and Their Therapeutic Application

Guha A, Wahi P, Lal G

ImmunoTargets and Therapy 2026, 15:604392

Published Date: 7 May 2026

Context-Dependent Survival Associations Between Interleukin-13 Expression and Immunotherapy in Advanced Solid Tumors

Fountzilas E, Kurzrock R, Nishizaki D, Szabo A, Pabla S, DePietro P, Jensen TJ, Kato S, Tsimberidou AM

ImmunoTargets and Therapy 2026, 15:578703

Published Date: 4 May 2026

RNA Sequencing Analyses and Validation of Immune-Related Genes in EBV-Specific Cytotoxic T Lymphocytes During Latent Infection

Guan Z, Ao X, Zhou L, Yu C, Zhang Z, Li D

ImmunoTargets and Therapy 2026, 15:568661

Published Date: 27 April 2026

Blinatumomab for Pediatric High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia: Safety, MRD Response and Survival in a Single-Center Retrospective Cohort

Mitura-Lesiuk M, Najda P, Rdzanek O, Bogucka J, Różycka K, Dubaj M, Zawitkowska J

ImmunoTargets and Therapy 2026, 15:603087

Published Date: 23 April 2026


Read more articles